MC, X., H, Q., CK, H., BN, Z., FZ, Y., F, L., . . . WF, X. (2021). Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy. European journal of pharmacology, 906, 174217. https://doi.org/10.1016/j.ejphar.2021.174217
Chicago Style (17th ed.) CitationMC, Xiao, et al. "Imatinib Inhibits the Malignancy of Hepatocellular Carcinoma by Suppressing Autophagy." European Journal of Pharmacology 906 (2021): 174217. https://doi.org/10.1016/j.ejphar.2021.174217.
MLA (9th ed.) CitationMC, Xiao, et al. "Imatinib Inhibits the Malignancy of Hepatocellular Carcinoma by Suppressing Autophagy." European Journal of Pharmacology, vol. 906, 2021, p. 174217, https://doi.org/10.1016/j.ejphar.2021.174217.
Warning: These citations may not always be 100% accurate.